AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013
Nov 19, 2013
30339_dirs_2013-11-19_d3579830-91f2-4461-aca3-dd0da57e7cbd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-11-19
Reporting Person: Flynn Karen (President, America's Region)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-19 | Common Stock | M | 5500.0000 | $22.8900 | Acquired | 16035.8092 | Direct |
| 2013-11-19 | Common Stock | S | 5500.0000 | $47.7500 | Disposed | 10535.8092 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-19 | Stock Option (Right to Buy) | $22.8900 | M | 5500.0000 | Disposed | 2018-06-11 | Common Stock (5500.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 311.7300 | Indirect |
| Common Stock | 579.9352 | Indirect |
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27